Browse studies

Find your next paid study

71 recruiting studies matching your filters

Mild Cognitive Impairment Community Screening, Early Detection, and Therapeutic Intervention to Slow Down, or Stop the Progression of the Cognitive Impairment.

This study aims to evaluate the efficacy of community-based early detection and targeted interventions, including stem cell therapy and wearable non-invasive b…

Mild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease Dementia+7 more

Estimated

~$10 – $8,750

Noah Tech, Corp.NCT07214974

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Le…

Alzheimer's DiseaseLewy Body DementiaParkinson's Disease

Estimated

~$10 – $1,125

Douglas ScharreNCT03019757

Evaluating the Retinal and Choroidal Microvasculature and Structure Using Multimodal Retinal and Choroidal Imaging in Neurodegenerative Disease: iMIND Research Study

This study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield …

Alzheimer's DiseaseMild Cognitive ImpairmentParkinson's Disease+12 more

Estimated

~$10 – $750

Duke UniversityNCT03233646

Observational

A Novel Intervention to Improve Care for Older Sexual and Gender Minority (SGM) Adults With Serious Illness and Especially Those With Alzheimer's Disease and Related Dementias (ADRD)

Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (A…

Sexual and Gender MinoritiesHospiceAlzheimer's Disease and Related Dementias

Estimated

~$10 – $6,250

University of Colorado, DenverNCT05877391

Alzheimer's Prevention Registry

The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide informatio…

Alzheimer's DiseaseDementia

Estimated

~$10 – $1,125

Banner HealthNCT02022943

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be…

Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more

Estimated

~$10 – $1,125

GAP Innovations, PBCNCT06584357

Observational

Impact of a Biophoton Therapy on Patients With Brain Disorders

Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dement…

Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury

Estimated

~$10 – $7,500

First Institute of All MedicinesNCT06147999

Prospective Study on Anti-Amyloid-β Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Coverage of Evidence Development (The Anti-Aβ mAb CED Study)

The Anti-Aβ mAb CED Study is a prospective, longitudinal coverage with evidence development (CED) study using clinical data, patient assessments, and administr…

Mild Alzheimer's DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Estimated

~$10 – $1,050

Centers for Medicare and Medicaid Services/ Coverage and Analysis GroupNCT06058234

Observational

Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease

Interventions that affect many different aspects of human ability rather than just one aspect of human health are more likely to be successful in preventing an…

Prodromal Alzheimer's Disease

Estimated

~$10 – $6,250

Emory UniversityNCT04029623

Observational

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after…

Critical IllnessDeliriumCognitive Impairment+5 more

Estimated

~$10 – $6,250

University of WashingtonNCT06411561

Phase 2

A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease

This study is a Phase 2b/3 clinical trial of a new candidate drug (T3D-959) to treat patients with mild-to-moderate Alzheimer's. The aims of the trial are to a…

Alzheimer's Disease

Estimated

~$10 – $8,750

T3D Therapeutics, Inc.NCT06964230